Renal disease, the metabolic syndrome, and cardiovascular disease

Ethnicity and Disease

Volumn 16, Issue SUPPL. 2, 2006, Pages

  Hoy, Wendy E ^a   Kondalsamy Chennakesavan, Srinivas ^a   McDonald, Stephen ^a   Wang, Zhiqiang ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Australian aborigines; Cardiovascular disease; Diabetes mellitus; Hypertension; Kidney disease; Metabolic syndrome; Type 2 diabetes

Indexed keywords

ABORIGINE; ALBUMINURIA; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMMUNITY; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK FACTOR; SCREENING; ADULT; ANTHROPOMETRY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DISEASE COURSE; ETHNOLOGY; FOLLOW UP; MASS SCREENING; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREVALENCE;

ADULT; ANTHROPOMETRY; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY DISEASES; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; PREVALENCE;

EID: 33746066416     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hoy WE. Insulin resistance/hyperinsulinemia and syndrome X: the basis of the accentuated susceptibility of transitional populations to renal disease? In: The 31st Annual Scientific Meeting of the Aust NZ Soc Nephrol; Canberra; 1995.
2. Hoy WE, McFarlane R, Pugsley DJ, Norman R, Mathews JD. Markers for cardiovascular and renal morbidity: expectations for an intervention programme in an Australian aboriginal community. Clin Exp Pharmacol Physiol. 1996;23(8):S33-S37.
3. Hoy WE. Screening and treatment for renal disease: the community model. Nephrology. 1998;4(Suppl III-IV):S90-S95.
4. Hoy WE. Reflections on the XVth ICN meeting: renal and cardiovascular protection in the developing world. Nephrol Dial Transplant. 2001;16(7):1509-1511.
5. Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M, et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Austtalian Aboriginal community. Kidney Int. 1998;54(4):1296-1304.
6. McDonald SP, Maguire GP, Duarte N, Wang XL, Hoy WE. Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian Aboriginal community. Atherosclerosis. 2004;177(2):423-431.
7. McDonald S, Maguire G, Duarte N, Wang XL, Hoy W. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. Clin Sci (Lond). 2004;106(2):121-128.
8. Hoy WE, Wang Z, VanBuynder P, Baker PR, McDonald SM, Mathews JD. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure. Kidney Int. 2001;60(1):249-256.
9. Hoy WE, McDonald SP. Albuminuria: marker or target in indigenous populations. Kidney Int Suppl. 2004(92):S25-S31.
10. McDonald SP, Hoy WE. Interfaces between cardiovascular and kidney disease among Aboriginal Australians. Adv Chronic Kidney Dis. 2005;12(1):39-48.
11. Wang Z, Hoy WE. Albuminuria and incident coronary heart disease in Australian Abotiginal people. Kidney Int. 2005;68(3):1289-1293.
12. de Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl. 2005(98):S25-S29.
13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
14. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
15. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
16. Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J, Sharma S, Katz I. A chronic disease outreach program for Aboriginal communities. Kidney Int. 2005;68(s98):S76-S82.
17. Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J, Sharma S. Kidney and related chronic disease profiles and risk factors in three remote Australian Aboriginal communities. Adv Chronic Kidney Dis. 2005;12(1):64-70.
18. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003;178(9):427-432.
19. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254(6):555-563.
20. McDonald S. Renal disease, cardiovascular disease and shared risk markers in remote Aboriginal communities [dissertation]. Adelaide: Flinders University; 2003.
21. McDonald SP, Wang Z, Hoy WE. Physical and biochemical predictors of death in an Australian aboriginal cohort. Clin Exp Pharmacol Physiol. 1999;26(8):618-621.
22. Australian Bureau of Statistics. The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples. ABS Catalogue no 4704.0. Available at: http://www.aihw.gov.au.
23. Spencer JL, Silva DT, Snelling P, Hoy WE. An epidemic of renal failure among Austtalian Aboriginals. Med J Aust. 1998;168(11):537-541.
24. McDonald SP, Russ GR. Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand. Kidney Int Suppl 2003(83):S123-S127.
25. Plant AJ, Condon J, Durling G. Northern Territory Health Outcomes. Morbidity and Mortality, 1979-1991. Darwin: Northern Territory Department of Health and Human Services; 1995.
26. Hoy WE, Wang Z, Baker PR, Kelly AM. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int Suppl. 2003(83):S66-S73.
27. Hoy WE, Rees M, Kile E, Mathews JD, Wang Z. A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int. 1999;56(3):1072-1077.
28. Singh GR, Hoy WE. Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community. Am J Kidney Dis. 2004;43(2):254-259.
29. Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J, Sharma S. The influence of birthweight on blood pressure, proteinuria and diabetes in young Aboriginal adults in remote communities in the Northern Territory. Nephrology. 2005;10(Suppl):A386.
30. Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J, Sharma S. Setting up chronic disease programs: perspectives from Aboriginal Australia. Ethn Dis. 2006;16(suppl 2):s2-74-s2-80.
31. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419.